Hyderabad pharma maker of branded generics and CDMO dosage forms/injectables; owns Noumed (Australia/NZ).
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 7 | 13 | 13 | 18 | 22 |
| Reserves | 24 | 61 | 80 | 189 | 469 |
| Borrowings | 69 | 119 | 94 | 78 | 333 |
| Other Liabilities | 34 | 75 | 85 | 91 | 600 |
| Total Liabilities | 134 | 268 | 272 | 376 | 1.4k |
| AssetsFixed Assets | 44 | 70 | 53 | 55 | 364 |
| CWIP | 2 | 0 | 0 | 2 | 212 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 88 | 198 | 219 | 320 | 848 |
| Total Assets | 134 | 268 | 272 | 376 | 1.4k |
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ActivitiesCash from Operating | -13 | -30 | 33 | 93 |
| Cash from Investing | -19 | -46 | 0 | -274 |
| Cash from Financing | 24 | 79 | -36 | 596 |
| SummaryCapital Expenditure | — | — | — | — |
| Free Cash Flow | -30 | -72 | 41 | -184 |
| FCF Margin | — | — | — | — |
We need at least a year of quarterly results to build a defensible base. Check back once more filings are in.
SAIPARENT · INSUFFICIENT_HISTORY
Guides on how to read this kind of business and the numbers that matter.